Morningside Venture Investments Ltd, 10% Owner at Amylyx Pharmaceuticals, Inc. (AMLX), sold 126,896 shares at $32.17 ($4.0M) on 2023-03-21, disclosed to the SEC on 2023-03-23.
Open-market sale of $4.0M AMLX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.69 | 34,641 | $1.1M | 27.1% |
| 2 | $31.69 | 34,641 | $1.1M | 27.1% |
| 3 | $32.17 | 28,807 | $927K | 22.9% |
| 4 | $32.17 | 28,807 | $927K | 22.9% |
| Total | $31.91 avg | 126,896 | $4.0M | 100% |
| Filing → |
| AMLX | SELL | 2023-03-29 | $4.9M | — | Filing → |
| AMLX | SELL | 2023-03-17 | $594K | — | Filing → |
| AMLX | SELL | 2023-03-16 | $14.9M | — | Filing → |